Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L2LQ
|
||||
Former ID |
DNC013805
|
||||
Drug Name |
Allylcarbamic Acid Biphenyl-3-yl Ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15NO2
|
||||
Canonical SMILES |
C=CCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C16H15NO2/c1-2-11-17-16(18)19-15-10-6-9-14(12-15)13-7-4-3-5-8-13/h2-10,12H,1,11H2,(H,17,18)
|
||||
InChIKey |
IVZVLOUIEAWCIN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.